Clinical trials
Phase 3 Pancreatic Neoplasms trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Corporation | 2 |
| Eli Lilly and Company | 1 |
| Erasmus Medical Center | 1 |
| Hoffmann-La Roche | 1 |
| Jon Unosson | 1 |
| Karolinska University Hospital | 1 |
| NantCell, Inc. | 1 |
| Pharmexa A/S | 1 |
| Royal Liverpool University Hospital | 1 |
| Sahlgrenska University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 12 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Aortic Aneurysm | 1 |
| Endocrine Gland Neoplasms | 1 |
| Jaundice | 1 |
| Liver Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.